Combination of
Animals
CD4-Positive T-Lymphocytes
/ immunology
Cell Differentiation
Combined Modality Therapy
Dendritic Cells
/ cytology
Drug Resistance
Heat-Shock Proteins
/ administration & dosage
Hot Temperature
Immunologic Memory
Immunophenotyping
Inflammation Mediators
Interleukin-6
/ biosynthesis
Leishmania donovani
/ drug effects
Leishmaniasis, Visceral
/ immunology
Mice
Mycobacterium
/ immunology
Protozoan Proteins
/ administration & dosage
Spleen
/ immunology
T-Lymphocyte Subsets
/ immunology
Leishmania donovani
T regulatory cells
Th1-Th17
drug-resistant
memory T cells
pre-DCs and cDCs
therapeutic adjuvant
Journal
Infection and immunity
ISSN: 1098-5522
Titre abrégé: Infect Immun
Pays: United States
ID NLM: 0246127
Informations de publication
Date de publication:
20 05 2020
20 05 2020
Historique:
received:
02
10
2019
accepted:
24
03
2020
pubmed:
2
4
2020
medline:
13
1
2021
entrez:
2
4
2020
Statut:
epublish
Résumé
The major issues in available therapeutic modalities against leishmaniasis are cost, toxicity, and the emergence of drug resistance. The aim of this work was to develop a successful therapeutic adjuvant against drug-resistant
Identifiants
pubmed: 32229617
pii: IAI.00222-19
doi: 10.1128/IAI.00222-19
pmc: PMC7240079
pii:
doi:
Substances chimiques
Heat-Shock Proteins
0
Inflammation Mediators
0
Interleukin-6
0
Protozoan Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 American Society for Microbiology.
Références
Sci Rep. 2017 Jul 20;7(1):5986
pubmed: 28729715
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18460-5
pubmed: 19015529
Parasitol Int. 2005 Jun;54(2):119-22
pubmed: 15866473
Lancet. 1998 May 23;351(9115):1540-3
pubmed: 10326536
J Immunol. 2005 Feb 1;174(3):1594-601
pubmed: 15661921
Vaccine. 2012 Sep 21;30(43):6198-209
pubmed: 22871353
J Infect Dis. 2006 Aug 1;194(3):294-301
pubmed: 16826476
Nat Immunol. 2001 Feb;2(2):102-7
pubmed: 11175801
J Immunol. 2008 Jun 15;180(12):8299-305
pubmed: 18523296
EMBO J. 1988 Sep;7(9):2895-901
pubmed: 3181145
Cell Stress Chaperones. 2002 Oct;7(4):339-46
pubmed: 12653478
Mol Immunol. 2008 Jul;45(12):3371-82
pubmed: 18538399
Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):E575-82
pubmed: 23341611
Immunol Res. 2008;41(2):123-36
pubmed: 18389179
J Immunol. 2007 Jan 1;178(1):271-9
pubmed: 17182564
J Exp Med. 2007 Apr 16;204(4):805-17
pubmed: 17389235
Antimicrob Agents Chemother. 2006 May;50(5):1788-97
pubmed: 16641451
J Immunol. 2003 Jun 1;170(11):5625-9
pubmed: 12759442
Clin Exp Immunol. 1994 Jun;96(3):416-21
pubmed: 8004810
J Immunol. 2003 Aug 1;171(3):1156-63
pubmed: 12874201
Infect Immun. 2016 Aug 19;84(9):2627-38
pubmed: 27354447
Sci Rep. 2017 Oct 31;7(1):14693
pubmed: 29089636
Cell Immunol. 2016 Nov;309:37-41
pubmed: 27444130
Semin Immunol. 2015 Dec;27(6):388-96
pubmed: 27040276
Med Microbiol Immunol. 2011 Nov;200(4):241-53
pubmed: 21533785
Clin Immunol. 2009 Jan;130(1):27-33
pubmed: 18845487
PLoS One. 2012;7(2):e31551
pubmed: 22347492
Eur J Immunol. 2006 Jul;36(7):1764-71
pubmed: 16791879
Immunity. 2001 Dec;15(6):985-95
pubmed: 11754819
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2696-708
pubmed: 26883702
J Glob Infect Dis. 2010 May;2(2):177-85
pubmed: 20606974
Nat Med. 2004 Oct;10(10):1104-10
pubmed: 15448686
PLoS One. 2012;7(7):e40265
pubmed: 22792256
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18
pubmed: 15225981
PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2995
pubmed: 25032977
J Immunol. 2005 Apr 15;174(8):4761-7
pubmed: 15814701
Blood. 2008 May 15;111(10):4892-901
pubmed: 18337562
Mol Biochem Parasitol. 2003 Aug 31;130(2):65-74
pubmed: 12946842
J Biol Chem. 2006 Aug 18;281(33):23766-75
pubmed: 16785229
Vaccine. 2008 Dec 9;26(52):6759-67
pubmed: 18950671
Trends Parasitol. 2006 Jan;22(1):32-40
pubmed: 16310413
Front Physiol. 2014 Jul 25;5:279
pubmed: 25120492
Eur J Immunol. 1998 Feb;28(2):687-95
pubmed: 9521079
Trends Parasitol. 2014 Oct;30(10):499-507
pubmed: 25190685
Front Immunol. 2018 May 03;9:952
pubmed: 29774029
Vaccine. 2012 Aug 24;30(39):5748-54
pubmed: 22796586
J Infect Dis. 2010 Jul 1;202(1):145-55
pubmed: 20500089
Immunology. 2010 Jan;129(1):75-86
pubmed: 19824919
Mol Ther. 2016 Feb;24(2):398-405
pubmed: 26643797
Int J Antimicrob Agents. 2007 Sep;30(3):229-35
pubmed: 17628445
Eur J Immunol. 2010 Jul;40(7):1830-5
pubmed: 20583029
Mol Immunol. 2002 Dec;39(9):531-6
pubmed: 12431386
J Immunol. 2018 Jan 1;200(1):163-176
pubmed: 29187586
Immunity. 2016 Sep 20;45(3):669-684
pubmed: 27637149
Proc Natl Acad Sci U S A. 1985 Jul;82(13):4414-7
pubmed: 3859870
J Biol Chem. 2002 Apr 26;277(17):15028-34
pubmed: 11836257
Clin Microbiol Rev. 2001 Apr;14(2):229-43
pubmed: 11292637
Blood. 2012 Mar 1;119(9):2003-12
pubmed: 22238324
Lancet. 2000 Nov 4;356(9241):1565-9
pubmed: 11075771